International Biotechs: What You Need to Know Before Entering the U.S. Pharmaceutical Market

For international biotechnology companies, the United States represents an extraordinary opportunity. It offers access to sophisticated clinical research institutions, experienced pharmaceutical investors, licensing partners, and a substantial market for innovative therapies. But the United States is not simply another geography into which a successful product can be introduced. A therapy developed in Europe, Asia, or another international market may have compelling science, encouraging clinical data, and a well-established development strategy…